Kayla Walsh

Kayla Walsh is the Editorial, Circulation, Awards Coordinator at PM360.

Healthcare Watch September 2022

Doctor Docs: Doctors Left Concerned After Roe v. Wade Overturn A recent Sermo study ...

Industry Briefs September 2022

Moderna v. Pfizer and BioNTech Moderna is suing Pfizer and BioNTech for patent infringement ...

Movers and Shakers September 2022

Pfizer Taps Alphabet’s Verily, Chief Marketing Officer Andreas “Drew” Panayiotou moved from Alphabet’s research ...

Healthcare Watch July/August 2022

Brand Beat: Juul Fights FDA Ban Shortly after banning Juul from selling its products, ...

Industry Briefs July/August 2022

Pfizer Takes Novel Approach to Helping Ukraine Unlike other corporations that have implemented sanctions ...

Movers and Shakers July/August 2022

Inozyme Pharma Names New Chief Medical Officer The rare disease focused biopharma announced the ...

Hearing from HCP Influencers

While social media had already been on the rise for disseminating medical information, the ...

Healthcare Watch June 2022

Med Device Department: Applying COVID Lessons to Monkeypox Learning from COVID-19, pharma is already ...

Industry Briefs June 2022

DeepIntent Dives into Streaming TV Ads According to research by DeepIntent and LG Ads ...

Movers and Shakers June 2022

Wall Street Analyst Joins Novartis Execs Well-known Sanford Bernstein analyst, Ronny Gal, PhD has ...

Industry Briefs May 2022

Patient Reach Guarantee by DeepIntent The healthcare advertising company DeepIntent will now guarantee its ...

Healthcare Watch May 2022

TeleMed Texts: Novartis Launches Streaming Style Service Novartis is pushing beyond the digital engagement ...

Healthcare Watch April 2022

Doctor Docs: Physicians are Fed Up with COVID-19 Misinformation Around the world, 55% of ...